Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading lower by 10.9% to $63.95 Monday afternoon, despite a lack of company-specific news for the session.

See Also: Viking Therapeutics’ Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say

Is VKTX A Good Stock To Buy?

An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Viking Therapeutics‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.

These are known as capital allocation programs. Viking Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.

For example, if you're looking to earn an annualized return of 15.87%, you'll need to buy a share of Ellington Residential by the Mar. 27, 2024. Once done, you can expect to receive a nominal payout of $0.08 on Apr. 25, 2024.

According to data from Benzinga Pro, VKTX has a 52-week high of $99.41 and a 52-week low of $8.28.